BMW 2004 Annual Report Download - page 64

63
impairment loss no longer exists, the impairment
loss is reversed up to the level of its rolled-forward
depreciated or amortised cost.
Financial assets are accounted for on the
basis of the settlement date. On initial recognition,
they are measured at acquisition cost, including
transaction costs.
Subsequent to initial recognition, available-for-
sale and held-for-trading financial assets are meas-
ured at fair value. When market prices are not
available, the fair value of available-for-sale financial
assets is measured using appropriate valuation tech-
niques e.g. discounted cash flow analysis based
on market information available at the balance sheet
date.
Loans and receivables which are not held by the
Group for trading (originated loans and receivables),
held-to-maturity financial investments and all finan-
cial assets for which published price quotations in
an active market are not available and whose fair
value cannot be determined reliably, are measured,
to the extent that they have a fixed term, at amor-
tised cost, using the effective interest method. When
the financial assets do not have a fixed term, they are
measured at acquisition cost.
In accordance with IAS 39 (Financial Instruments:
Recognition and Measurement), assessments are
made regularly as to whether there is any objective
evidence that a financial asset or group of assets
may be impaired. If any such evidence exists, an
impairment loss is included in net profit or loss for
the period. Gains and losses on available-for-sale
financial assets are recognised directly in equity until
the financial asset is disposed of or is determined to
be impaired, at which time the cumulative loss pre-
viously recognised in equity is included in net profit
or loss for the period.
Investments in non-consolidated group com-
panies reported in non-current financial assets
are measured at cost, since published price quota-
tions in an active market are not available and their
fair value cannot be determined reliably.
Associated companies are generally consolidated
using the equity method, whereby the investment
is measured at the Group’s share of the equity of the
company.
Investments in other companies are measured
at their quoted market price or fair value. When these
values are not available or cannot be determined
reliably, investments in other companies are meas-
ured at cost.
Non-current marketable securities and loans
are measured according to the category of financial
asset to which they are classified. No held-for-trading
financial assets are included under this heading.
Inventories of raw materials,supplies and goods
for resale are stated at the lower of average acquisi-
tion cost and net realisable value.
Work in progress and finished goods are stated
at the lower of manufacturing cost and net realis-
able value. Manufacturing cost comprises all costs
which are directly attributable to the manufacturing
process and an appropriate proportion of produc-
tion-related overheads.This includes production-
related depreciation and an appropriate proportion
of administrative and social costs.
Financing costs are not included in acquisition
or manufacturing costs.
With the exception of derivative financial instru-
ments, all receivables and other current assets
are items originated by the Group and are not held
for trading. They are measured at amortised cost.
Receivables with maturities of over one year which
bear no or lower than market interest rate are dis-